[{"from": "human", "value": "What can you tell me about this molecule? [C][C@H1][C][/C][=C][/C@@H1][Branch2][Branch1][N][C@@H1][C][C][C@H1][Ring1][Ring2][C][N][C][C@@][Branch1][P][C][C][C][C][=C][Ring1][=Branch1][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][Cl][C][O][C][=C][Ring1][P][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][=Branch1][C][=O][N][S][=Branch1][C][=O][=Branch1][C][=O][C@@H1][Ring2][Ring2][=Branch1][C][O][C]"}, {"from": "gpt", "value": "The molecule is an inhibitor of induced myeloid leukemia cell differentiation protein MCL-1 (myeloid cell leukemia-1), with potential pro-apoptotic and antineoplastic activities. Upon administration, tapotoclax binds to and inhibits the activity of MCL-1. This disrupts the formation of MCL-1/Bcl-2-like protein 11 (BCL2L11; BIM) complexes and induces apoptosis in tumor cells. MCL-1, an anti-apoptotic protein belonging to the Bcl-2 family of proteins, is upregulated in cancer cells and promotes tumor cell survival."}]